Dianne Bosch completed her medical degree (MSc) at the University of Groningen in 2018. Following medical school, she worked as a medical doctor (ANIOS) at Tergooi Hospital (Hilversum, the Netherlands), initially in Surgery and later in Urology. Since January 2021, she has been working at Radboud University Medical Center (Nijmegen, the Netherlands) as a PhD candidate. Until 2024, she served as the coordinating investigator for the CAPRI-3 registry, which focuses on metastatic prostate cancer. In 2024, she transitioned into her residency training to become an urologist. Dianne has published several studies in the field of urology, with a focus on prostate cancer and real-world evidence. In her free time, she has been an active council and board member for several professional societies and committees.
Dianne Bosch completed her medical degree (MSc) at the University of Groningen in 2018. Following medical school, she worked as a medical doctor (ANIOS) at Tergooi Hospital (Hilversum, the Netherlands), initially in Surgery and later in Urology. Since January 2021, she has been working at Radboud University Medical Center (Nijmegen, the Netherlands) as a PhD candidate. Until 2024, she served as the coordinating investigator for the CAPRI-3 registry, which focuses on metastatic prostate cancer. In 2024, she transitioned into her residency training to become an urologist. Dianne has published several studies in the field of urology, with a focus on prostate cancer and real-world evidence. In her free time, she has been an active council and board member for several professional societies and committees.